Cellgenesbiotechnology is a biotechnology company focused on developing innovative cell-based therapies and genetic engineering solutions. The company aims to advance personalized medicine through cutting-edge research in cellular reprogramming, gene editing, and regenerative therapies, targeting a range of diseases and medical conditions. While detailed public information is limited, the organization is positioned within the biotech sector, seeking collaborations and investments to accelerate its pipeline.
Cellgenesbiotechnology is profiled on the APIs.io network. Tagged areas include Biotechnology, Cell Therapy, Gene Editing, Regenerative Medicine, and Healthcare.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: cellgenesbiotechnology
name: Cellgenesbiotechnology
description: Cellgenesbiotechnology is a biotechnology company focused on developing innovative cell-based therapies and genetic
engineering solutions. The company aims to advance personalized medicine through cutting-edge research in cellular reprogramming,
gene editing, and regenerative therapies, targeting a range of diseases and medical conditions. While detailed public information
is limited, the organization is positioned within the biotech sector, seeking collaborations and investments to accelerate
its pipeline.
url: https://raw.githubusercontent.com/api-evangelist/cellgenesbiotechnology/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment pass 2026-10-07 (modular-v1; was harvest)
specificationVersion: '0.20'
created: '2026-10-07'
modified: '2026-10-07'
tags:
- Biotechnology
- Cell Therapy
- Gene Editing
- Regenerative Medicine
- Healthcare
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: Hosts
url: hosts/cellgenesbiotechnology-hosts.yml
- type: Vendors
url: vendors/cellgenesbiotechnology-vendors.yml
- type: DomainSecurity
url: security/cellgenesbiotechnology-domain-security.yml
- type: Website
url: https://equityzen.com/company/cellgenesbiotechnology
apis: []
x-coverage:
state: none
reason: not-a-software-company
detail: Cellgenesbiotechnology provides biotech services and does not expose a software API.
evidence:
- url: https://www.cellgenes.com
status: 200
checked: '2026-10-07'
x-enrichment:
date: '2026-10-07'
status: enriched
artifacts_added: 3
pass: modular-v1
engine: identity=local,contract=local,surfaces=local,docs=local,regulatory=local
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.
Kin Score
How this is scored →